Skip navigation

Neuropsychiatry and genomics

The Neuropsychiatry and genomics working group aim to investigate the range of psychiatric disorders resulting from COVID-19 and their potential mechanisms. Working with experts from across the UK from the full spectrum of relevant clinical and academic neurosciences we hope to answer these key questions to better understand and treat these important complications of COVID-19.

Leads

Professor Gerome Breen, King's College London
Dr Tim Nicholson, King's College London.

Members

Dr Jay Amin, University of Southampton
Professor Matthew Broome, Birmingham University
Professor Ed Bullmore, University of Cambridge
Dr Matt Butler, King’s College London
Professor Alan Carson, Edinburgh University
Professor Jonathan Cavanagh, University of Glasgow
Dr David Christmas, Dundee University
Professor Anthony David, University College London
Professor Neil Harrison, Cardiff University
Dr Matthew Hotopf, King’s College London
Dr Gabriella Lewis, South London and Maudsley NHS Foundation Trust
Dr Ryan McIlwaine, Queen’s University Belfast
Dr Ciaran Mulholland, Queen’s University Belfast
Dr Akshay Nair, King’s College London
Dr Alish Palmos, King’s College London
Dr Tom Pollak, King’s College London
Professor John Paul Taylor, Newcastle University
Professor Nicholas Wood, University College London.

Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)